Literature DB >> 24700417

Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation.

Xingwang Zhang1, Tianpeng Zhang, Xiaotong Zhou, Hongming Liu, Hua Sun, Zhiguo Ma, Baojian Wu.   

Abstract

Oral delivery of anticancer drugs remains challenging because of limited water-solubility and/or poor permeability. Here, we aimed to enhance the oral bioavailability of tripterine (TRI, a plant-derived anticancer compound) using lipid nanospheres (LNs) and to determine the mechanisms of oral absorption. TRI-loaded LNs (TRI-LNs) were prepared by rapid dispersion of an ethanol mixture of TRI, lecithin, sodium oleate, and soybean oil into water. The obtained LNs were 150 nm in size with a high value of entrapment efficiency (99.95%). TRI-LNs were fairly stable and the drug release was negligible (<0.2%) in simulated physiological fluid. The pharmacokinetic results showed that LNs significantly enhanced the oral bioavailability of TRI with a relative bioavailability of 224.88% (TRI suspensions was used as a reference). The mechanistic studies demonstrated that improved intestinal permeability and post-enterocyte lymphatic transport were mainly responsible for the enhanced oral absorption. Our findings suggested that LNs may be a viable oral carrier for poorly bioavailable drugs.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  absorption potential; bioavailability; lipids; nanospheres; oral drug delivery; permeability; tripterine

Mesh:

Substances:

Year:  2014        PMID: 24700417     DOI: 10.1002/jps.23967

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

Review 1.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

2.  Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Authors:  Xingwang Zhang; Tianpeng Zhang; Yali Lan; Baojian Wu; Zhihai Shi
Journal:  AAPS PharmSciTech       Date:  2015-07-18       Impact factor: 3.246

3.  Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation.

Authors:  Yuchen Zhang; Xingwang Zhang; Hongming Liu; Shaohui Cai; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2015-02-26

4.  Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation.

Authors:  Xingwang Zhang; Guijiang Chen; Tianpeng Zhang; Zhiguo Ma; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2014-11-26

Review 5.  Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases.

Authors:  Rita Cascão; João E Fonseca; Luis F Moita
Journal:  Front Med (Lausanne)       Date:  2017-06-15

6.  Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma.

Authors:  Jinran Li; Yuxi Jia; Peng Zhang; Huailin Yang; Xianling Cong; Lin An; Chunsheng Xiao
Journal:  Int J Nanomedicine       Date:  2020-02-19

Review 7.  Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications.

Authors:  Pushkaraj Rajendra Wagh; Preshita Desai; Sunil Prabhu; Jeffrey Wang
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

8.  Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement.

Authors:  Rong Lu; Shan Liu; Qilin Wang; Xia Li
Journal:  Int J Nanomedicine       Date:  2015-07-31

9.  Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles.

Authors:  Tianpeng Zhang; Huan Wang; Yanghuan Ye; Xingwang Zhang; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2015-10-01

10.  Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.

Authors:  Vanna Sanna; Jean Christopher Chamcheu; Nicolino Pala; Hasan Mukhtar; Mario Sechi; Imtiaz Ahmad Siddiqui
Journal:  Int J Nanomedicine       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.